2009 IW 1000 Company Profile

2009 IW 1000 Company Profile

Novartis AG

Pharmaceuticals

Switzerland

2009 IW 1000 Rank:

Current Rank : 85

Prior Rank : 83

Executive 1 : Daniel Vasella, M.D., Chief Executive Officer

Executive 2 : Raymund Breu, Chief Financial Officer

85 of 1000

Revenue (US$ Millions)	$42,584
Revenue Growth (%)	9.34%
Net Income (US$ Millions)	$8,233
Earnings Per Share (US$)	$3.59
Total Equity (US$ Millions)	$50,288
Profit Margin (%)	19.33%
Return on Assets (%)	16.73%
Debt To Equity Ratio (%)	0.04%
Market Capitalization (US$ Millions)	NA

Subscribe to IW Newsletters